Penn Spinout Vittoria Biotherapeutics Emerges from Stealth Mode with $10M Seed Round

The new company hopes to overcome the current limitations of CAR T-cell therapeutics by using unique cell engineering and gene editing technologies.

Read the full article at: www.bizjournals.com